An emerging medical discipline that involves using genomic information about an individual as part of their clinical care and the health outcomes. Otogenetics is applying genomic medicine and making an impact in the fields of oncology, pharmacology, rare, undiagnosed and chronic diseases.
Combines whole exome sequencing and RNA sequencing to identify molecular fingerprint of a patient, including variants and CNV. The molecular data was used to model a unique treatment plan for individual cancer patients who had failed generic treatment.
Combines whole exome sequencing and RNA sequencing from germline and tumor tissues to profile tumor molecularly. The results are used to identify the unique antigens of the patient’s tumor to elicit immunotherapy targeting the tumors specifically.
Otogenetics offers gene testing for specific diseases, such as hearing loss and heart diseases. The tests reveal precisely the cause of the diseases and provide guidance to select the most appropriate intervention and prevention plan. e.g. identification of Usher gene mutations as the cause of hearing loss could advise patients to take preventive measure to delay the onset of blindness, and the gene target for gene therapy to treat blindness.
The tests can identify the risks for sudden death from cardiomyopathy and prevent onset of diseases such as biotin deficiency that can be managed by biotin supplement to prevent the pleotid health problems associated and prevent onset of hearing loss.
Once your tests are completed, we want you to have the information you need to diagnose the root cause of health conditions
©Copyright 2024 Houston Diagnostics Lab. All Rights Reserved.